SErIES IAEA HumAn HEAltH SErIES IAEA Hum

More documents

Recommendations

Info

(d) (vi) Specially qualified or trained clinical supervisors who are competent in instruction; (vii) Radiation training and monitoring requirements for participants. Discuss aspects of the clinical training programme with both supervisors and participants to ascertain if the programmes: (i) Have sufficient numbers of supervisors to instruct or mentor; (ii) Are held in a clinical environment offering the needed experience; (iii) Are of a sufficient duration for the acquisition of adequate skills; (iv) Have identified and appropriate assessment. 6.2.1.3. Miscellaneous educational and training programmes The audit team should identify the availability of and access to miscellaneous facility programmes, such as: (a) (b) (c) (d) Clinical education (e.g. image evaluation, radiographic techniques, equipment information and resuscitation); Professional meetings and interdisciplinary meetings; Statutory and regulatory training (e.g. radiation safety, fire safety, lifting and handling); Internal and external audit reviews. 6.2.2. Research The audit team should: (a) (b) (c) Determine if research is carried out in the facility, including: (i) Clinical research, possibly including participation in clinical trials; (ii) Research projects undertaken by staff as a part of education and training. Review identified research programmes for the following attributes: (i) A clear policy statement on ethics, governance, and the role and structure of the research committee of the institute/facility; (ii) Conformity with recognized ethical standards, including those related to patient dose; (iii) An infrastructure to support research. Discuss with relevant staff members: (i) The availability of high quality scientific research personnel; (ii) Published research output; (iii) Adequacy of research funding; (iv) Adequacy of time allowed for research; 64
(d) (v) Regularity of research meetings; (vi) Access to a statistics professional; (vii) Adequacy of library and computing facilities. Determine if minor research projects undertaken by staff as a part of education and training have: (i) A designated coordinator; (ii) Regular research meetings; (iii) Access to experienced researchers. 65
Page 1 and 2:
IAEA HumAn HEAltH SErIES no. 4 Comp
Page 3 and 4:
COMPREHENSIVE CLINICAL AUDITS OF DI
Page 5 and 6:
IAEA HUMAN HEALTH SERIES No. 4 COMP
Page 7 and 8:
FOREWORD The application of radiati
Page 9 and 10:
CONTENTS 1. INTRODUCTION . . . . .
Page 11 and 12:
5.1.3. Quality assurance processes
Page 13 and 14:
1. INTRODUCTION 1.1. CLINICAL AUDIT
Page 15 and 16:
1.1.3. Confidentiality of audits Co
Page 17 and 18:
evidence based medical research is
Page 19 and 20:
As a result of the comprehensive cl
Page 21 and 22:
The facility/institution is respons
Page 23 and 24:
2.4.2. Review The review process wi
Page 25 and 26: 2.5.1. Title page and contents page
Page 27 and 28: 2.6. DISSEMINATION OF THE REPORT Th
Page 29 and 30: A QA committee should be establishe
Page 31 and 32: Lines of authority should be reflec
Page 33 and 34: —Medical support equipment such a
Page 35 and 36: (g) (h) (i) Make an assessment of t
Page 37 and 38: (c) (d) (e) (f) Examine the facilit
Page 39 and 40: (c) (d) Consider policy in regard t
Page 41 and 42: equire a written policy and procedu
Page 43 and 44: Once examination scheduling has bee
Page 45 and 46: Documentation of the details of the
Page 47 and 48: There should be a radiographer resp
Page 49 and 50: —Recorded; —Systematically eval
Page 51 and 52: 4.2.1.5. Pre-procedure screening an
Page 53 and 54: (f) (g) (h) (i) (j) (k) (l) (m) (n)
Page 55 and 56: 4.2.5. Report communication The aud
Page 57 and 58: —Digital image receptors (compute
Page 59 and 60: (b) (c) (d) Ensuring that appropria
Page 61 and 62: 5.1.2.2. Occupational and public ex
Page 63 and 64: (f) (g) Performance criteria for al
Page 65 and 66: Dosimetry for those subjected to ra
Page 67 and 68: 5.2.1.3. Management support The aud
Page 69 and 70: (b) (c) Discuss the facility’s po
Page 71 and 72: (g) (h) (i) Discuss with the medica
Page 73 and 74: Professionals engaging in such prog
Page 75: 6.2. THE AUDIT PROGRAMME 6.2.1. Edu
Page 80 and 81: Six months before audit Audited ins
Page 82 and 83: Day 1: Morning: All audit team memb
Page 84 and 85: Appendix III AUDIT REPORT FORMAT: S
Page 86 and 87: Appendix IV AUDIT REPORT FORMS The
Page 88 and 89: Audit criteria Adequacy Comments Su
Page 120 and 121: 5.3. AUDIT REPORT FORMS FOR TECHNIC
Page 126 and 127:
Audit criteria Adequacy Comments Su
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
6.3. AUDIT REPORT FORMS FOR EDUCATI
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Appendix V NOTES ON PHYSICIST MEASU
Page 146 and 147:
V.2.3. Other measurements The other
Page 148 and 149:
[16] COMMISSION OF THE EUROPEAN COM
Page 151 and 152:
Annex I APPLICATION FORM IAEA Clini
Page 153 and 154:
Department Vision Statement and imm
Page 155 and 156:
List of equipment Equipment type Id
Page 157 and 158:
Annex II LIST OF ITEMS REQUESTED TO
Page 159 and 160:
Annex III EQUIPMENT-SPECIFIC CHECKL
Page 161 and 162:
Form RXR — Items to be reviewed b
Page 163 and 164:
Form RXR — Items to be reviewed b
Page 165 and 166:
Form FIF — Items to be reviewed b
Page 167 and 168:
FORM FOR A MAMMOGRAPHY QA PROGRAMME
Page 169 and 170:
Form MAM — Items to be reviewed b
Page 171 and 172:
Form CTQ — Items to be reviewed b
Page 173 and 174:
FORM FOR A SCREEN-FILM AND PROCESSO
Page 175 and 176:
FORM FOR A COMPUTED OR DIGITAL RADI
Page 177 and 178:
FORM FOR A VIEWING CONDITIONS (ANAL
Page 179 and 180:
FORM FOR A QA PROGRAMME FOR HARD CO
Page 181 and 182:
Form DPQ — Items to be reviewed b
Page 183 and 184:
FORM FOR A QA PROGRAMME FOR ULTRASO
Page 185 and 186:
FORM FOR A QA PROGRAMME FOR MRI For
Page 187 and 188:
Form MRI — Items to be reviewed b
Page 189 and 190:
TECHNIQUE OBSERVATION SHEET Radiogr
Page 191 and 192:
Tube focus to tabletop distance d F
Page 193 and 194:
K i Patient: Radiographic Calculati
Page 195 and 196:
Manufacturer of phantom: __________
Page 197 and 198:
P KA Patient: Fluoro 1 DETERMINATIO
Page 199 and 200:
Phantom: MGD 1 CALCULATION OF INCID
Page 201 and 202:
Phantom: CT1 MEASUREMENT OF C a,100
Page 203 and 204:
REFERENCE TO ANNEX IV [IV-1] INTERN
Page 205:
CONTRIBUTORS TO DRAFTING AND REVIEW
Page 208 and 209:
Korea, Republic of KINS Inc., Infor
show all

SErIES IAEA HumAn HEAltH SErIES IAEA Hum

Create successful ePaper yourself

Delete template?

Save as template?